Direct inhibition of the NOTCH transcription factor complex

  • Nature. 2009 Nov 12;462(7270):182-8. doi: 10.1038/nature08543.
Raymond E Moellering  1 Melanie Cornejo Tina N Davis Cristina Del Bianco Jon C Aster Stephen C Blacklow Andrew L Kung D Gary Gilliland Gregory L Verdine James E Bradner
Affiliations
  • 1. Department of Chemistry & Chemical Biology, Harvard University, Cambridge, Massachusetts 02138, USA.
Abstract

Direct inhibition of transcription factor complexes remains a central challenge in the discipline of ligand discovery. In general, these proteins lack surface involutions suitable for high-affinity binding by small molecules. Here we report the design of synthetic, cell-permeable, stabilized alpha-helical peptides that target a critical protein-protein interface in the Notch transactivation complex. We demonstrate that direct, high-affinity binding of the hydrocarbon-stapled peptide SAHM1 prevents assembly of the active transcriptional complex. Inappropriate Notch activation is directly implicated in the pathogenesis of several disease states, including T-cell acute lymphoblastic leukaemia (T-ALL). The treatment of leukaemic cells with SAHM1 results in genome-wide suppression of NOTCH-activated genes. Direct antagonism of the Notch transcriptional program causes potent, NOTCH-specific anti-proliferative effects in cultured cells and in a mouse model of NOTCH1-driven T-ALL.